EP Patent

EP2399571A1 — Therapeutic compositions comprising ingenol-3-angelate

Assigned to Leo Laboratories Ltd · Expires 2011-12-28 · 14y expired

What this patent protects

Ingenol angelate is a potent anticancer agent, and can be stabilised by dissolving it in an aprotic solvent in the presence of an acidic buffer.

USPTO Abstract

Ingenol angelate is a potent anticancer agent, and can be stabilised by dissolving it in an aprotic solvent in the presence of an acidic buffer.

Drugs covered by this patent

Patent Metadata

Patent number
EP2399571A1
Jurisdiction
EP
Classification
—
Expires
2011-12-28
Drug substance claim
No
Drug product claim
No
Assignee
Leo Laboratories Ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.